Lancet 359:1929–1936PubMedCrossRef 59. Hui SL, Slemenda CW, Johnston C (1998) Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 81:1804–1809CrossRef 60. Kanis JA, Johansson H, Oden A et al (2004) A family history of fracture and fracture risk: a meta-analysis. Bone 35:1029–1037PubMedCrossRef 61. Kanis JA, Johansson H, Oden A et al (2004) A meta-analysis of prior corticosteroid

use and fracture risk. J Bone Miner Res 19:893–899PubMedCrossRef 62. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef 63. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman J (2006) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162CrossRef 64. De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: https://www.selleckchem.com/products/3-methyladenine.html a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef 65. Klotzbuecher CM, Ross PD, Landsman PD, Abbott TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical

synthesis. J Bone Miner Res 15:721–739PubMedCrossRef 66. Kanis JA, McCloskey E, Johansson H, Oden A, SB-715992 datasheet Leslie WD (2012) FRAX® with and without bone mineral density. Calcif Tissue Int 90:1–13PubMedCrossRef 67. Schwartz AV, Vittinghoff E, Bauer DC et al (2011)

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA 305:2184–2192PubMedCrossRef 68. Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res 27:301–308PubMedCrossRef 69. Nguyen ND, Frost click here SA, Center JR, Eisman JA, Nguyen TV (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444PubMedCrossRef 70. Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229PubMedCrossRef 71. McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef 72. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of PFT�� research buy biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int 11(Suppl 6):S2–S17PubMedCrossRef 73. Johnell O, Oden A, De Laet C, Garnero P, Delmas PD, Kanis JA (2002) Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523–526PubMedCrossRef 74.